51 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
52 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. MYLAN PHARMACEUTICALS INC. et al |
2:09-cv-02073 |
D.N.J. |
|
|
|
|
53 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
54 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
55 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
56 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
57 |
WARNER CHILCOTT LABORATORIES IRELAND LIMITED et al v. IMPAX LABORATORIES, INC. et al |
2:08-cv-06304 |
D.N.J. |
|
|
|
|
58 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
59 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
60 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-05930 |
D.N.J. |
|
|
|
|
61 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
62 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
63 |
NOVARTIS CORPORATION et al v. MYLAN LABORATORIES INC. et al |
2:07-cv-04918 |
D.N.J. |
|
|
|
|
64 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
65 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
66 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
67 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. et al v. MYLAN PHARMACEUTICALS,INC. |
2:07-cv-04214 |
D.N.J. |
|
|
|
|
68 |
JANSSEN PHARMACEUTIC, et al v. MYLAN PHARMACEUTICAL |
2:03-cv-06220 |
D.N.J. |
|
|
|
|
69 |
JANSSEN PHARMACEUTIC, et al v. MYLAN PHARMACEUTICAL |
2:03-cv-06220 |
D.N.J. |
|
|
|
|
70 |
CEPHALON, INC. v. MYLAN PHARMACEUTICAL, et al |
2:03-cv-01394 |
D.N.J. |
|
|
|
|
71 |
ALZA CORPORATION, et al v. MYLAN LABORATORIES, et al |
2:02-cv-00230 |
W.D.Pa. |
|
|
|
|
72 |
ALZA CORPORATION, et al v. MYLAN LABORATORIES, et al |
2:02-cv-00230 |
W.D.Pa. |
|
|
|
|
73 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|
74 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|
75 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
76 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
77 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
78 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
79 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
80 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
81 |
SCHERING CORPORATION v. MYLAN PHARMACEUTICAL |
2:00-cv-01657 |
D.N.J. |
|
|
|
|
82 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
|
|
|
83 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
|
|
|
84 |
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al |
1:23-cv-00556 |
D.Del. |
|
|
|
|
85 |
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al |
1:20-md-00445 |
D.Del. |
|
|
|
|
86 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
87 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
88 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
89 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:20-cv-00090 |
N.D.W.Va. |
|
|
|
|
90 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
91 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
92 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
93 |
Bausch Health US, LLC et al v. Mylan Pharmaceuticals Inc. |
1:20-cv-00046 |
N.D.W.Va. |
|
|
|
|
94 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-01699 |
D.Del. |
|
|
|
|
95 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
96 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
97 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
98 |
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. et al |
1:18-cv-00226 |
N.D.W.Va. |
|
|
|
|
99 |
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00202 |
N.D.W.Va. |
|
|
|
|
100 |
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al |
1:18-cv-00184 |
N.D.W.Va. |
|
|
|
|